BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29170515)

  • 21. Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Mou Y; Wang D; Xing R; Nie H; Mou Y; Zhang Y; Zhou X
    Cancer Biomark; 2018; 23(1):95-106. PubMed ID: 29991128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LncRNAs expression signatures of hepatocellular carcinoma revealed by microarray.
    Liu WT; Lu X; Tang GH; Ren JJ; Liao WJ; Ge PL; Huang JF
    World J Gastroenterol; 2014 May; 20(20):6314-21. PubMed ID: 24876753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum long noncoding RNA urothelial carcinoma-associated 1: A novel biomarker for diagnosis and prognosis of hepatocellular carcinoma.
    Zheng ZK; Pang C; Yang Y; Duan Q; Zhang J; Liu WC
    J Int Med Res; 2018 Jan; 46(1):348-356. PubMed ID: 28856933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long non-coding RNAs as biomarkers and therapeutic targets: Recent insights into hepatocellular carcinoma.
    Qiu L; Tang Q; Li G; Chen K
    Life Sci; 2017 Dec; 191():273-282. PubMed ID: 28987633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sp1 cooperates with Sp3 to upregulate MALAT1 expression in human hepatocellular carcinoma.
    Huang Z; Huang L; Shen S; Li J; Lu H; Mo W; Dang Y; Luo D; Chen G; Feng Z
    Oncol Rep; 2015 Nov; 34(5):2403-12. PubMed ID: 26352013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long noncoding RNAs: Novel insights into hepatocelluar carcinoma.
    He Y; Meng XM; Huang C; Wu BM; Zhang L; Lv XW; Li J
    Cancer Lett; 2014 Mar; 344(1):20-27. PubMed ID: 24183851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-regulation of long non-coding RNA GAS5-AS1 and its prognostic and diagnostic significance in hepatocellular carcinoma.
    Wang Y; Jing W; Ma W; Liang C; Chai H; Tu J
    Cancer Biomark; 2018; 22(2):227-236. PubMed ID: 29660898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical significance of long non-coding RNAs MALAT1 and CASC2 in the diagnosis of HCV-related hepatocellular carcinoma.
    Golam RM; Khalil MAF; Shaker OG; Ahmed TI; Elguaad MKA; Hassan EA; El-Ansary MRM; Ismail A; Kandil YI; Mohammed OA; Doghish AS
    PLoS One; 2024; 19(5):e0303314. PubMed ID: 38739668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A MALAT1/HIF-2α feedback loop contributes to arsenite carcinogenesis.
    Luo F; Sun B; Li H; Xu Y; Liu Y; Liu X; Lu L; Li J; Wang Q; Wei S; Shi L; Lu X; Liu Q; Zhang A
    Oncotarget; 2016 Feb; 7(5):5769-87. PubMed ID: 26735578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin inhibits tumorigenesis in HBV-induced hepatocellular carcinoma by suppressing HULC overexpression caused by HBX.
    Jiang Z; Liu H
    J Cell Biochem; 2018 Jun; 119(6):4482-4495. PubMed ID: 29231260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The long non-coding RNA MALAT1 promotes the migration and invasion of hepatocellular carcinoma by sponging miR-204 and releasing SIRT1.
    Hou Z; Xu X; Zhou L; Fu X; Tao S; Zhou J; Tan D; Liu S
    Tumour Biol; 2017 Jul; 39(7):1010428317718135. PubMed ID: 28720061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma level of metastasis-associated lung adenocarcinoma transcript 1 is associated with liver damage and predicts development of hepatocellular carcinoma.
    Konishi H; Ichikawa D; Yamamoto Y; Arita T; Shoda K; Hiramoto H; Hamada J; Itoh H; Fujita Y; Komatsu S; Shiozaki A; Ikoma H; Ochiai T; Otsuji E
    Cancer Sci; 2016 Feb; 107(2):149-54. PubMed ID: 26614531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation.
    Lai MC; Yang Z; Zhou L; Zhu QQ; Xie HY; Zhang F; Wu LM; Chen LM; Zheng SS
    Med Oncol; 2012 Sep; 29(3):1810-6. PubMed ID: 21678027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of long non-coding RNAs to reveal potential prognostic biomarkers in hepatocellular carcinoma.
    Ma Y; Luo T; Dong D; Wu X; Wang Y
    Gene; 2018 Jul; 663():148-156. PubMed ID: 29684484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association of lncRNA-HULC polymorphisms with hepatocellular cancer risk and prognosis.
    Wang BG; Lv Z; Ding HX; Fang XX; Wen J; Xu Q; Yuan Y
    Gene; 2018 Sep; 670():148-154. PubMed ID: 29803923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
    Shi XM; Teng F
    Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
    Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
    Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Invasion and metastasis-related long noncoding RNA expression profiles in hepatocellular carcinoma.
    Gao Y; Chen G; Zeng Y; Zeng J; Lin M; Liu X; Liu J
    Tumour Biol; 2015 Sep; 36(10):7409-22. PubMed ID: 25900874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Small Nucleolar RNA Host Gene 18 Acts as a Tumor Suppressor and a Diagnostic Indicator in Hepatocellular Carcinoma.
    Liu XF; Thin KZ; Ming XL; Shuo-Li ; Ping-Luo ; Man-Zhu ; Li ND; Tu JC
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818794494. PubMed ID: 30126319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of long non-coding RNA PCAT-1 expression in human hepatocellular carcinoma.
    Yan TH; Yang H; Jiang JH; Lu SW; Peng CX; Que HX; Lu WL; Mao JF
    Int J Clin Exp Pathol; 2015; 8(4):4126-31. PubMed ID: 26097602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.